Latest filing published 31 Oct 2022 for Fusion Antibodies plc, €4,881.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +32.1%Entry £0.66 · Close at T+365 £0.86
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sonya Ferguson: trading record in brief
Sonya Ferguson is a declared insider of Fusion Antibodies plc, with filings sourced from RNS (LSE). Between 2 July 2019 and 31 October 2022, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €28k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 1 purchase and no sales.
On 31 October 2022 came the latest disclosure, an open-market purchase for €4,881 in Fusion Antibodies plc. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sonya Ferguson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ £0.4191XLON, London Stock ExchangeISIN GB00BDQZGK16FCA-NSM:4563073Canonical exit: 29 Jan 2023 (T+90)
- 30,000 shares@ £0.695100.0% of flowLondon Stock Exchange, XLONISIN GB00BDQZGK16FCA-NSM:LSE20190703160914_14135577_20200326185125204_34467-2Canonical exit: 30 Sept 2019 (T+90)
2 of 2 declarations